2003 William B. Kirlin Research Award Recipient

 

Robert H. Cox, Ph.D. - Lankenau Institute for Medical Research

 

Statins Inhibit Peroxynitrite Mediated Vascular Dysfunction”

 

 

Paul Joseph DiMuzio, Sr., M.D. - Thomas Jefferson University Hospital

 

“A Novel Tissue-Engineerede Vascular Conduit: Seeding of Decellularized Venous Allograft With Autologous Mesenchymal Stem Cell”

 

 

2003 Millennium Pharmaceutical Research Award Recipient

 

Gurusher Panjrath, MBBS - Drexel University College of Medicine

 

“Effect of Doxorubicin on Serum Lipid Levels in Humans”

 

My research involves understanding the mechanism of Doxorubicin induced cardiomyopathy. Doxorubicin, a commonly used drug to treat cancer, causes heart failure. The underlying mechanism of cardiac damage is still not clear. We are trying to understand the various effects of this drug on physiologic processes and their relationship to cardiotoxicity. This grant from the Cardiovascular Institute of Philadelphia will help us focus on metabolic abnormalities and their role in cardiac damage in patients undergoing therapy with Doxorubicin. Research from this generous support has provided me with an opportunity to pursue this important study and help me understand an important mechanism which may prevent cardiac damage in a significant population of cancer patients.